Earnings NewsHealthcareWave Life Sciences GAAP EPS of -$0.61 misses by $0.06, revenue of $1.76M misses by $11.98MMar. 03, 2022 7:34 AM ETWave Life Sciences Ltd. (WVE) StockBy: Urvi Shah, SA News Editor Wave Life Sciences press release (NASDAQ:WVE): Q4 GAAP EPS of -$0.61 misses by $0.06. Revenue of $1.76M (-81.4% Y/Y) misses by $11.98M. Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsElectric vehicles 2024 and beyond: Why Tesla, BYD and Rivian may lap the fieldShari Redstone evaluates options for Paramount amid interest - FTHeat-pump shipments fall for seventh straight monthGoogle's Gemini will make for a solid 2024: CitiUnit Corporation declares $2.50 dividend and a special dividend of $15See More »About WVESymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgWVE--Wave Life Sciences Ltd.TBPH--Theravance Biopharma, Inc.TSNDF--TerrAscend Corp.ANTX--AN2 Therapeutics, Inc.EOLS--Evolus, Inc.CompareTrending AnalysisTrending News